PLEASANTON, Calif., March 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, has completed another hypoxia trial with the University of California, San Francisco ...

Repeated sprint training in hypoxic conditions has emerged as a promising strategy to enhance performance in team sports, where short bursts of high-intensity activity and rapid recovery are critical.

Preliminary results demonstrated high accuracy of SpO 2 and heart rate data in its pivotal hypoxia trial, bringing the Company one step closer to developing a medical device PLEASANTON, Calif., Dec.

PLEASANTON, Calif., Aug. 9, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the ...

A further drop in SpO2 below this threshold is defined as hypobaric hypoxia - or low blood oxygen level at higher altitude. Alcohol relaxes blood vessel walls, increasing the heart rate during sleep, ...